Clinical Trial Update: Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine Patch [Phase 3]

View source ↗

Summary

A Phase 3 trial conducted by Sanofi assessed the efficacy and safety of rimonabant as an aid to smoking cessation with or without a nicotine patch; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Sanofi | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED